Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. 1996

N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
Division of Infectious Diseases & International Health, Duke University Medical Center, Durham, North Carolina 27710, USA.

Nitric oxide (NO)-related activity has been shown to be protective against Plasmodium falciparum in vitro. It has been hypothesized, however, that excess NO production contributes to the pathogenesis of cerebral malaria. The purpose of this study was to compare markers of NO production [urinary and plasma nitrate + nitrite (NOx)], leukocyte-inducible nitric oxide synthase type 2 (NOS2), and plasma TNF-alpha and IL-10 levels with disease severity in 191 Tanzanian children with and without malaria. Urine NOx excretion and plasma NOx levels (corrected for renal impairment) were inversely related to disease severity, with levels highest in subclinical infection and lowest in fatal cerebral malaria. Results could not be explained by differences in dietary nitrate ingestion among the groups. Plasma levels of IL-10, a cytokine known to suppress NO synthesis, increased with disease severity. Leukocyte NOS2 antigen was detectable in all control children tested and in all those with subclinical infection, but was undetectable in all but one subject with cerebral malaria. This suppression of NO synthesis in cerebral malaria may contribute to pathogenesis. In contrast, high fasting NOx levels and leukocyte NOS2 in healthy controls and asymptomatic infection suggest that increased NO synthesis might protect against clinical disease. NO appears to have a protective rather than pathological role in African children with malaria.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008297 Male Males
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
May 1999, Infection and immunity,
N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
September 1998, Molecular medicine (Cambridge, Mass.),
N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
January 2018, PloS one,
N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
August 2001, The Journal of infectious diseases,
N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
August 2004, Infection and immunity,
N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
November 1995, The Journal of clinical investigation,
N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
February 1998, The Journal of rheumatology,
N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
May 2016, Oncotarget,
N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
April 1999, Journal of surgical oncology,
N M Anstey, and J B Weinberg, and M Y Hassanali, and E D Mwaikambo, and D Manyenga, and M A Misukonis, and D R Arnelle, and D Hollis, and M I McDonald, and D L Granger
February 1994, Cancer research,
Copied contents to your clipboard!